Xoma(美國)

Xoma

美國Xomawww.xoma.com美國Xoma成立于1981年，是一家生物制藥公司發(fā)現(xiàn)，開發(fā)和制造用于治療炎癥，自身免疫，傳染性疾病和腫瘤治療性抗體的重點(diǎn)。XOMALtd.(XOMA),incorporatedin1981,isabiopharmaceuticalcompanyfocusedonthediscovery,developmentandmanufactureoftherapeutic antibodiesdesignedtotreatinflammatory,autoimmune,infectiousandoncologicaldiseases.TheCompany’sproductdevelopmentpipelineincludesXOMA052,ananti-interleukin-1beta(IL-1beta)antibody,XOMA3AB,abiodefenseanti-botulismantibodycandidate,andpreclinicalantibodydiscoveryprogramsinseveralindications.XOMAhaveanintegratedproductdevelopmentplatform,extendingfrompreclinicalsciencetodevelopmentandmanufacturing.TheCompany’stechnologieshavecontributedtothesuccessofmarketedantibodyproducts,includingLUCENTIS(ranibizumabinjection)forwetage-relatedmaculardegenerationandCIMZIA(certolizumabpegol)forrheumatoidarthritisa